AJOVY
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51759-202 -
Package NDC
51759-202-10 -
Package NDC
51759-202-11 -
Package NDC
51759-202-22 -
Application number
BLA761089 -
SPL ID
4e729b85-d3b0-445d-9cba-9326b4e2291f -
SPL set ID
98e344ea-5916-4947-b6f2-4a76ccc04b6b -
UNII
PF8K38CG54 -
RxCUI
2056695 -
RxCUI
2056700 -
RxCUI
2287903 -
RxCUI
2287905
What the source publishes
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Active ingredients
- fremanezumab-vfrm
- Form
- INJECTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "AJOVY",
"splId": "4e729b85-d3b0-445d-9cba-9326b4e2291f",
"labels": [
{
"setId": "98e344ea-5916-4947-b6f2-4a76ccc04b6b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98e344ea-5916-4947-b6f2-4a76ccc04b6b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98e344ea-5916-4947-b6f2-4a76ccc04b6b"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Teva Pharmaceuticals USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 CONTAINER in 1 CARTON (51759-202-10) / 1.5 mL in 1 CONTAINER",
"package_ndc": "51759-202-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20200329"
},
{
"sample": true,
"description": "1 CONTAINER in 1 CARTON (51759-202-11) / 1.5 mL in 1 CONTAINER",
"package_ndc": "51759-202-11",
"identifierStatus": "well-formed",
"marketing_start_date": "20200329"
},
{
"sample": false,
"description": "3 CONTAINER in 1 CARTON (51759-202-22) / 1.5 mL in 1 CONTAINER",
"package_ndc": "51759-202-22",
"identifierStatus": "well-formed",
"marketing_start_date": "20200831"
}
],
"productId": "51759-202_4e729b85-d3b0-445d-9cba-9326b4e2291f",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "51759-202",
"deaSchedule": null,
"genericName": "fremanezumab-vfrm",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "FREMANEZUMAB",
"strength": "225 mg/1.5mL"
}
],
"applicationNumber": "BLA761089",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200329",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"PF8K38CG54"
],
"rxcui": [
"2056695",
"2056700",
"2287903",
"2287905"
],
"spl_set_id": [
"98e344ea-5916-4947-b6f2-4a76ccc04b6b"
],
"manufacturer_name": [
"Teva Pharmaceuticals USA, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51759-202_4e729b85-d3b0-445d-9cba-9326b4e2291f"